Anyone read SA "FDA's Janet Woodcock say clinical trial system broken" Under new rules she mentions a master protocol " a single treatment for multiple diseases ". Is she saying 1 trial for more than 1 disease ? Also says guidance on RWE (real world evidence) and a new framework on it's use to be released before end of year. Is this reason for delay ?
Market Data 
Markets 
AI
